A large international study led by Dr Tomas Kalincik of The University of Melbourne together with the global MSBase Consortium has shown that the treatments alemtuzumab (Lemtrada) and natalizumab (Tysabri)…read more
A blood test for determining the subtype of MS could be as little as two years away following the discovery of a blood biomarkerread more
The physical effects of MS, for example on walking, are the ones that the broader community are most aware of as being a part of MS.read more
There is a great deal of interest in the MS community and reported in the media about the influence of lifestyle factors affecting MS disease course and outcomes.read more
One of the core goals of the International Progressive MS Alliance is to not only bring together researchers and fund research into progressive MS, but also to focus the attention…read more
You are not as old as you think you are! We often think that our bodies are static, that it is the same body we have always had, maybe a…read more
Contrary to the notion that current treatments only benefit early stage MS, new research has shown that taking treatments that modify the immune system can improve the disease course even…read more
In a new study published recently, tissue from the MS Research Australia Brain Bank was used. Led by Associate Professor Roger Pamphlett from the University of Sydney, to study the…read more
A new study by Dr Cullen O’Gorman and Professor Simon Broadley of Gold Coast Hospital and Griffith University in Queensland, has shown that secondary progressive MS can develop, on average,…read more
New research has just been released which has shown that a new plant derived compound can delay and reduce MS symptoms in an animal model of MS. Natural products continue…read more
The ‘latitude effect’ for developing MS, has long been recognised for some time, where the latitude at which a person lives can influence their overall risk of developing MS. This…read more
Some people with MS have described finding benefit in switching to a gluten free diet, however, there is no strong scientific evidence that gluten contributes to the risk of developing…read more
While treatment options are currently available for relapsing MS, there are no treatments for the progressive forms of the disease. This is a significant unmet need in the MS community…read more
Over the last 15 years the treatment landscape has substantially improved for people with relapsing remitting MS, and in Australia 11 disease modifying therapy options are currently available for people…read more
There are many stories in the media about autologous haematopoietic stem cell transplant, also known as bone marrow transplant, AHSCT or HSCT, as a treatment for MS.read more
Living with MS isn’t just about the physical symptoms, MS can also impact on one’s psychological well-being. Both the physical and the psychological aspects of MS can intrude into many…read more
There is substantial evidence that stress increases MS disease activity in those with established MS. Some research has shown, for example, that stressful life events, such as the death of…read more
The Australian Therapeutic Goods Administration (TGA) has approved the registration of disease modifying multiple sclerosis (MS) medication, Zinbryta (daclizumab) on the Australian Register of Therapeutic Goods.read more
There is a great deal of interest in the MS community as to whether taking control of lifestyle factors can change disease outcomes, and there is certainly growing evidence that…read more
New research has just been published looking at the role of microRNAs or ‘genetic switches’ in secondary progressive MS. microRNAs are tiny pieces of genetic material found in cells which…read more
